Appeal Upheld Against NICE Recommendation in England
Filed with ASX · · 3 pages · English
Clinuvel Pharmaceuticals Limited on 6ix
Story so far
Earlier from Clinuvel Pharmaceuticals
- S&P DJI Announces September 2018 Quarterly Rebalance
- US FDA Update
- CLINUVEL completes SCENESSE FDA Filing
- NICE maintains position not to recommend SCENESSE
- CLINUVEL Regulatory Update
Later from Clinuvel Pharmaceuticals
- CUV103 Singaporean Phase II vitiligo study results
- US FDA sets PDUFA date for SCENESSE
- US FDA extends PDUFA date for SCENESSE
- CLINUVEL declares Full Year Dividend
- Appendix 4E and Preliminary Financial Report Reissued
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals